Holding(s) in Company
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB0004536594
Issuer Name
ADVANCED MEDICAL SOLUTIONS GROUP PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
JPMorgan Chase & Co.
City of registered office (if applicable)
Country of registered office (if applicable)
US
4. Details of the shareholder
Name
City of registered office
Country of registered office
J.P. Morgan Securities PLC
5. Date on which the threshold was crossed or reached
01-Sep-2026
6. Date on which Issuer notified
04-Sep-2026
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A)
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached
3.978496
0.903657
4.882153
10721411
Position of previous notification (if applicable)
4.546887
0.887751
5.434638
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible)
Number of direct voting rights (DTR5.1)
Number of indirect voting rights (DTR5.2.1)
% of direct voting rights (DTR5.1)
% of indirect voting rights (DTR5.2.1)
GB0004536594
8736944
3.978496
Sub Total 8.A
8736944
3.978496%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument
Expiration date
Exercise/conversion period
Number of voting rights that may be acquired if the instrument is exercised/converted
% of voting rights
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument
Expiration date
Exercise/conversion period
Physical or cash settlement
Number of voting rights
% of voting rights
Cash-settled Equity Swap
15/10/2026
15/10/2026
Cash
29991
0.013657
Cash-settled Equity Swap
03/11/2026
03/11/2026
Cash
8027
0.003655
Cash-settled Equity Swap
27/11/2026
27/11/2026
Cash
8943
0.004072
Cash-settled Equity Swap
02/12/2026
02/12/2026
Cash
16185
0.007370
Cash-settled Equity Swap
05/01/2027
05/01/2027
Cash
212634
0.096826
Cash-settled Equity Swap
15/02/2027
15/02/2027
Cash
6930
0.003156
Cash-settled Equity Swap
02/03/2027
02/03/2027
Cash
29001
0.013206
Cash-settled Equity Swap
20/04/2027
20/04/2027
Cash
11340
0.005164
Cash-settled Equity Swap
19/05/2027
19/05/2027
Cash
1092000
0.497258
Cash-settled Equity Swap
27/05/2027
27/05/2027
Cash
147087
0.066978
Cash-settled Equity Swap
14/06/2027
14/06/2027
Cash
17965
0.008181
Cash-settled Equity Swap
02/07/2027
02/07/2027
Cash
27259
0.012413
Cash-settled Equity Swap
05/07/2027
05/07/2027
Cash
313730
0.142862
Cash-settled Equity Swap
03/08/2027
03/08/2027
Cash
54562
0.024846
Cash-settled Equity Swap
23/08/2027
23/08/2027
Cash
2692
0.001226
Cash-settled Equity Swap
25/08/2027
25/08/2027
Cash
6008
0.002736
Cash-settled Equity Swap
02/09/2027
02/09/2027
Cash
2
0.000001
Cash-settled Equity Swap
02/05/2030
02/05/2030
Cash
13
0.000006
Cash-settled Equity Swap
21/05/2031
21/05/2031
Cash
7
0.000003
Cash-settled Equity Swap
20/06/2031
20/06/2031
Cash
91
0.000041
Sub Total 8.B2
1984467
0.903657%
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling person
Name of controlled undertaking
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
JPMorgan Chase & Co.
J.P. Morgan Securities PLC
3.495673
4.398632%
JPMorgan Chase & Co.
J.P. Morgan SE
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
If date does not apply, explain below
11. Additional Information
Chain of controlled undertakings:
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Securities PLC (100%)
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan SE (100%)12. Date of Completion
04-Sep-2026
13. Place Of Completion
London
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDHOLURORRNBUKAAR
Recent news on Advanced Medical Solutions
See all newsH.B. Fuller Company Adv Medical Solutns. - Update on Bidco's Financing Arrangements
Holding(s) in Company
H.B. Fuller Company Adv Medical Solutns. - Publication of Financing Materials
H.B. Fuller Company Adv Medical Solutns. - Publication of Financing Materials.
Adv Medical Solutns. Canaccord GenuityGrp - Holding(s) in Company